Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2979-2984

  Kolialexi, Aggeliki ^a   Tsangaris, G Th ^b   Kitsiou, S ^a   Kanavakis, E ^a   Mavrou, A ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

Chromosome abnormalities; Hematologic malignancies; Karyotype; Molecular cytogenetics; Review

Indexed keywords

MEMBRANE ANTIGEN;

CELL COUNT; CHROMOSOME ABERRATION; CHROMOSOME PAINTING; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; HUMAN GENOME PROJECT; INTERPHASE; KARYOTYPE; LEUKEMOGENESIS; METAPHASE; MITOSIS INDEX; MOLECULAR GENETICS; MOLECULAR PROBE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW; TRISOMY 12;

CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; CYTOGENETIC ANALYSIS; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION;

EID: 22944458534     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Kearney L: The impact of the new fish technologies on the cytogenetics of haematological malignancies. Br J Haematol 4: 648-658, 1999.
2. Chen Z and Sanderbrg AA: Molecular cytogenetic aspects of hematologic malignancies: clinical implications. Am J Med Genet 115: 130-141, 2002.
3. Harris NL, Jaffe ES, Diebold J, Frandrin G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia. Clin Oncol 17: 3835-3849, 1997.
4. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.): World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2001.
5. Vardiman JW, Harris NL and Brunning RD: The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100: 2292-2302, 2002.
6. Bloomfield CD, Goldman A, Hossfeld D and de la Chapelle A: Fourth International Workshop on Chromosomes in Leukemia: clinical significance of chromosomal abnormalities in acute non lymphoblastic leukemia. Cancer Genet Cytogenet 11: 332-350, 1984.
7. Grimwade D: The clinical significance of cytogenetic abnormalities in acute myeloid leukemia. Best Pract Res Clin Haematol 14: 497-529, 2001.
8. Mrozek K, Prior TW, Edwards C et al: Comparison of cytogenetic and molecular genetic detection of t (8;21) and inv (16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 19: 2482-2492, 2001.
9. Minoz L, Nomded JF, Villamor N et al: Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flowcytometry in the detection of residual leukemic cells. Leukemia 17: 76-82, 2003.
10. Seabright M: A rapid banding technique for human chromosomes. Lancet 30: 971-972, 1971
11. Yunis JG: High resolution of human chromosomes. Science 26: 1268-1270, 1976.
12. Shaffer LG, Ledbetter DH and Lupski JR: Molecular cytogenetics of contiguous gene syndromes: mechanisms and consequences of gene dosage imbalance. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds.) Metabolic and Molecular Basis of Inherited Disease, 8th edition, MacGraw Hill, New York, NY, Chap. 65, 1999.
13. Buckle VJ and Kearney L: New methods in cytogenetics. Curr Opin Genetics Develop 4: 374-382, 1994.
14. Cremer T, Landegent J and Bruckner A: Detection of chromosome aberrations in the human interphase nucleus by visualization of specific target DNAs with radioactive and non-radioactive in situ hybridization techniques: detection of trisomy 18 with probe L1. 84. Human Genetics 74: 346-352, 1986.
15. Fischer K, Scholl C, Salat J, Frohling S, Schénk K, Bentz M, Stilgenbauer S, Lichter P and Dohner H: Deciding and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 88: 3962-3971, 1996.
16. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA and Rowley JD: Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 79: 1796-1801, 1992.
17. Garcia-Marco JA, Price CM and Catovsky D: Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genet Cytogenet 94: 52-58, 1997.
18. Stilgenbauer S, Leupolt E, Ohl S, Weiss G, Schröder M, Fischer K, Bentz M, Lichter P and Döhner H: Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization. Cancer Res 55: 3475-3477, 1995.
19. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M and Lichter P: High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 81: 2118-2124, 1993.
20. Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W and Lichter P: p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85: 1580-1589, 1995.
21. Cano I, Martinez J, Quevedo E, Pinilla J, Martin-Recio A, Rodriguez A, Castaneda A, Lopez R, Perez-Pino T and Hernandez-Navarro F: Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy. Cancer Genet Cytogenet 90: 118-124, 1996.
22. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P and Dohner H: Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nature Med 3: 1155-1159, 1997.
23. Anastasi J, Thangavely M, Vardiman JW, Hooberman AL, Bian ML, Larson RA and Le Beau MM: Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of relapse after allogeneic bone marrow transplantation. Blood 77: 1087-1091, 1991.
24. Wessman M, Popp S, Ruutu T, Volin L, Cremer T and Knuutila S: Detection of residual host cells after bone marrow transplantation using non-isotopic in situ hybridisation and karyotype analysis. Bone Marrow Transplant 11: 279-284, 1993.
25. Kasprzyk A and Seeker-Walker LM: Increased sensitivity of minimal residual disease detection by interphase FISH in acute lymphoblastic leukemia with hyperdiploidy. Leukemia 11: 429-135, 1997.
26. Price CM, Kanfer EJ, Colman SM, Westwood N, Barret AJ and Greaves MF: Simultaneous genotypic and immunophenotypic analysis of interphase cells using dual-colour fluorescence: a demonstration of lineage involvement in polycythemia vera. Blood 80: 1033-1038, 1992.
27. Nylund SJ, Verbeek W, Larramendy ML, Ruutu T, Heinonen K, Hallman H and Knuutila S: Cell lineage involvement in four patients with myelodysplastic syndrome and t (1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet Cytogenet 70: 120-124, 1993.
28. Torlakovic E, Litz CE, McClure JS and Brunning RD: Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 8: 1940-1943, 1994.
29. Soenen V, Fenaux P, Flactif M, Lepelley P, Lai JL, Cosson A and Preudhomme C: Combined immunophenotying and in situ hybridization (FICTION): a rapid method to study cell lineage involvment in myelodysplastic syndromes. Br J Haematol 90: 701-706, 1995.
30. Haferlach T, Winkemann M, Nickenig C, Meeder M., Ramm-Petersen L, Schoch R, Nickelsen M, Weber-Matthiesen K, Schlegelberger B, Schoch C, Nickelsen M, Weber-Mathiesen K, Schlegelberger B, Schoch C, Gassmann W and Löffler H: Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukemia? An answer at the single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 97: 99-106, 1997.
31. Katz F, Reeves BR, Alexander S, Kearney L and Chessells J: Leukaemia arising in donor cells following allegeneic bone marrow transplantation for thalassaemia demonstrated by immunological, DNA and cytogenetic analysis. Br J Haematol 85: 326-331, 1993.
32. Ried T, Schröck E, Ning Y and Wienberg J: Chromosome painting: a useful art. Hum Mol Genet 7: 1619-1626, 1998.
33. Collins C, Kuo WL, Segraves R, Fuscoe J, Pinkel D and Gray JW: Construction and characterization of plasmid libraries enriched in sequences from single human chromosomes. Genomics 11: 997-1006, 1991.
34. Telenius H, Pelmear AH, Tunnacliffe A, Carter NP, Behmel A, Ferguson-Smith MA, Nordenskjold M, Pfragner R and Ponder BAJ: Cytogenetic analysis by chromosome painting using degenerate oligonucleotide-primed- polymerase chain reaction amplified flow-sorted chromosomes. Genes Chrom Cancer 4: 257-263, 1992.
35. Vooijs M, Yu LC, Tkachuk D, Pinkel D, Johnson D and Gray JW: Libraries for each human chromosome, constructed from sorter-enriched chromosomes by using linker-adaptor PCR. Am J Hum Genet 52: 586-597, 1993.
36. Guan XY, Zhang H, Bittner M, Jiang Y, Meltzer P and Trent VJ: Chromosome arm painting probes. Nat Genet 12: 10-11, 1996.
37. Dauwerse JG, Wiegant J, Raap AK, Breuning MH and van Ommen GJB: Multiple colors by fluorescence in situ hybridization using radiolabelled DNA probes create a molecular karyotype. Hum Mol Genet 1: 593-598, 1992.
38. Tkachuk DC, Kohler S and Cleary ML: Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 71: 691-700, 1992.
39. Sacchi N, Magnani I, Kearney L, Wijsman J, Hagemeijer A and Darfler M: Interphase cytogenetics of the t 8;21) (q22;q22) associated with acute mylogenous leukemia by two-color fluorescence in situ hybridisation. Cancer Genet Cytogenet 79: 97-103, 1995.
40. Jaju RJ, Boultwood J, Oliver FJ, Kostrzewa M, Fidler C, Parker N, McPherson JD, Morris SW, Wainscoat JS and Kearney L: Molecular cytogenetic delineation of the critical deleted region in the 5q- syndrome. Genes Chrom Cancer 22: 251-256, 1998.
41. Knight SJL, Horsley SW, Regan R, Lawrie M, Maher EJ, Cardy DLN, Flint J and Kearney L: Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet 5: 1-8, 1997.
42. Speicher MR, Ballard SG and Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12: 368-375, 1996.
43. Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y and Ried T: Multicolor spectral karyotyping of human chromosomes. Science 273: 494-497, 1996.
44. Kallionemi A, Kallionemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
45. Bentz M, Plesch A, Stilgenbauer S, Döhner H and Lichter P: Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chrom Cancer 21: 172-175, 1998.
46. Forozan F, Karhu R, Kononen J, Kallioniemi A and Kallioniemi OP: Genome screening by comparative genomic hybridization. Trends Genet 13: 405-409, 1997.
47. Bentz M, Döhner H, Huck K, Schütz B, Ganser A, Joos S, du Manior S and Lichter P: Comparative genomic hybridization in the investigation of myeloid leukemias. Genes Chrom Cancer 12: 193-200, 1995a.
48. Bentz M, Huck K, du Manoir S, Joos S, Werner CA, Fischer K, Döhner H and Lichter P: Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85: 3610-3618, 1995b.
49. Joos S, Otãno-Joos MI, Ziegler S, Brüderlein S, du Manior S, Bentz M, Möller P and Lichter P: Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87: 1571-1578, 1996.
50. Monni O, Joensuu H, Franssila K and Knuutila S: DNA copy number changes in diffuse large B-cell lymphoma: comparative genomic hybridization study. Blood 87: 5269-5278, 1996.
51. El-Rifai W, Elonen E, Larramendy M, Ruutu T and Knuutila S: Chromosomal breakpoints and changes in DNA copy number in refractory acute myeloid leukemia. Leukemia 11: 958-963, 1997.
52. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T and Lichter P: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chrom Cancer 20: 399-407, 1997.
53. Snijders AM, Nowak N, Segraves, R, Blackwood S, Brown N, Conroy J, Hamilton G, Hindle AK, Huey B and Kimura K et al: Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29: 263-264, 2001.
54. Yu W, Ballif BC, Kashork CD, Heilstedt HA, Howard LA, Cai WW, White LD, Liu W, Beaudet AL, Bejjani BA et al: Development of a comparative genomic hybridization microarray and demonstration of its utility with 25 well-characterized 1p36 deletions. Hum Mol Genet 12: 2145-2152, 2003.
55. Shaffer LG and Bejjani BA: A cytogeneticist's perspective on genomic microarrays. Hum Reprod Update 10(3): 221-226, 2004.
56. Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF, Nessling M, Moller P, Dohner H and Lichter P et al: Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 22: 1425-1429, 2003.